DK1064943T3 - Kombination med antilipemisk aktivitet, der i det væsentlige er fri for toksiske virkninger og bivirkninger som fölge af antilipemsike lægemidler - Google Patents

Kombination med antilipemisk aktivitet, der i det væsentlige er fri for toksiske virkninger og bivirkninger som fölge af antilipemsike lægemidler

Info

Publication number
DK1064943T3
DK1064943T3 DK99830415T DK99830415T DK1064943T3 DK 1064943 T3 DK1064943 T3 DK 1064943T3 DK 99830415 T DK99830415 T DK 99830415T DK 99830415 T DK99830415 T DK 99830415T DK 1064943 T3 DK1064943 T3 DK 1064943T3
Authority
DK
Denmark
Prior art keywords
antilipemic
combination
drugs
essentially free
side effects
Prior art date
Application number
DK99830415T
Other languages
Danish (da)
English (en)
Inventor
Arduino Arduini
Alessandro Peschechera
Paolo Carminati
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1064943T3 publication Critical patent/DK1064943T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK99830415T 1999-06-30 1999-06-30 Kombination med antilipemisk aktivitet, der i det væsentlige er fri for toksiske virkninger og bivirkninger som fölge af antilipemsike lægemidler DK1064943T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99830415A EP1064943B1 (de) 1999-06-30 1999-06-30 Lipidsenkende Kombination, die im wesentlichen frei ist von toxischen Wirkungen und Nebenwirkungen der Lipidsenker

Publications (1)

Publication Number Publication Date
DK1064943T3 true DK1064943T3 (da) 2005-06-06

Family

ID=8243483

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99830415T DK1064943T3 (da) 1999-06-30 1999-06-30 Kombination med antilipemisk aktivitet, der i det væsentlige er fri for toksiske virkninger og bivirkninger som fölge af antilipemsike lægemidler

Country Status (6)

Country Link
EP (1) EP1064943B1 (de)
AT (1) ATE288751T1 (de)
DE (1) DE69923670T2 (de)
DK (1) DK1064943T3 (de)
ES (1) ES2237073T3 (de)
PT (1) PT1064943E (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0667833B2 (ja) * 1985-11-28 1994-08-31 雪印乳業株式会社 経腸栄養剤
CA2007983C (en) * 1989-01-18 1996-12-10 Michael S. Brown Coenzyme q10 with hmg-coa reductase inhibitors
IT1293067B1 (it) * 1997-07-01 1999-02-11 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento di patologie causate da alterato metabolismo lipidico

Also Published As

Publication number Publication date
DE69923670T2 (de) 2006-03-09
DE69923670D1 (de) 2005-03-17
EP1064943A1 (de) 2001-01-03
PT1064943E (pt) 2005-06-30
ES2237073T3 (es) 2005-07-16
EP1064943B1 (de) 2005-02-09
ATE288751T1 (de) 2005-02-15

Similar Documents

Publication Publication Date Title
BG105559A (en) STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR
CY1118206T1 (el) Φαρμακευτικη συνθεση για δερματικη χρηση για να θεραπευεται ψωριαση που περιλαμβανει καλσιποτριολη και βηταμεθαζονη
TR200003735T2 (tr) Osteoporoz ve menopoz sendromuna bağlı rahatsızlıkların önlenmesi ve tedavileri
NO20043309L (no) Legemiddelleveringssystemer for hindring og behandling av vaskulaere sykdommer som innbefatter rapamycin og derivater derav
EP1399414A4 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
CL2004001174A1 (es) Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia
ATE263558T1 (de) Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
NO20043702L (no) 8-azaprostaglandinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
BR9908690A (pt) Composição farmacêutica contendo estatina e aspirina
BR9908004A (pt) Composto, composição e método para prevençãoou supressão de uma infecção viral
DK1498411T3 (da) Diketohydrazinderivatforbindelser og medikamenter indeholdende forbindelserne som den aktive bestanddel
CY1112318T1 (el) Εξωτερικο παρασκευασμα για διαδερμικη χορηγηση που περιεχει μη στεροειδες αντι-φλεγμονωδες αναλγητικο
BR9801048B1 (pt) composiÇço e processos de reduÇço da velocidade de cristalizaÇço de um pesticida e de controle de uma praga.
BR0212298A (pt) Composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
EP1314425A4 (de) Medizinische zusammenstellung zur prophylaxe und behandlung von herzversagen
CU23043A1 (es) Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico.
DK0773022T3 (da) Farmaceutisk sammensætning til behandling af rhinitis indeholdende sympathomimetika og pantothenol og/eller pantothensyre
ATE438626T1 (de) 4,4-difluor-1,2,3,4-tetrahydro-5h-1- benzazepinderivate und deren salze
FI951856A0 (fi) Farmaseuttinen koostumus osteoporoosin hoitamiseksi
NO20006646L (no) Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel
EP1142573A4 (de) Antibakterielle medizinische zusammenstellung
DK1064943T3 (da) Kombination med antilipemisk aktivitet, der i det væsentlige er fri for toksiske virkninger og bivirkninger som fölge af antilipemsike lægemidler
CL2004001421A1 (es) Composicion farmaceutica que comprende un compuesto derivado de 1,4-dipiperidin-4-il-piperazina; y su uso para la prevencion y/o tratamiento del dolor.
NO20063867L (no) Hypokolesterolemisk sammensetning omfattende et staten og et antiflatulensmiddel
EE200300468A (et) Pravastatiini stabiilne farmatseutiline kompositsioon